Fludarabine and mitoxantrone for the refractory relapse treatment of B-cell low-grade non-Hodgkin lymphoma (NHL):: LACOHG first interim report (Latin American Cooperative Oncology Hematology Group).

被引：0
|
作者：
Baltazar-Arellano, Severiano
Pimentel, Patricia
Vera, Luis
Bezares, Fernando
Malaga, Jose
Huamani-Z, Julia
Montante, Antonio
Rivas-Vera, Silvia
Carrasco-Yalan, Antonio A.
Beltran-Garate, Brady E.
机构：
[1] Ctr Med Noreste, Monterrey, Mexico
[2] Hosp Edgardo Rebagliati Martins, Dept Hematol Oncol, Lima, Peru
[3] Hosp Alvarez, Dept Hematol, Buenos Aires, DF, Argentina
[4] Hosp Natl Del Sur, Dept Hematol, Arequipa, Peru
[5] Hosp Gen Mexico OD, Mexico City, DF, Mexico
[6] Inst Nacl Cancerol, Mexico City, DF, Mexico
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4665
引用
收藏
页码：247B / 248B
页数：2
相关论文
共 50 条
  • [1] Fludarabine, mitoxantrone and dexametasone in the treatment of relapsed and refractory low-grade non-Hodgkin lymphoma.
    Sawczuk-Chabin, J
    Kalinka, E
    Centkowski, P
    Budziszewska, K
    Ceglarek, B
    Najda, J
    Blasinska-Morawiec, M
    Sulek, K
    Holowiecki, J
    Konopka, L
    Warzocha, K
    BLOOD, 2005, 106 (11) : 265B - 265B
  • [2] Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: A phase II study of the Hellenic Cooperative Oncology Group
    Dimopoulos, MA
    Fountzilas, G
    Papageorgiou, E
    Kiamouris, C
    Mantzios, G
    Anagnostopoulos, A
    Nicolaides, C
    Economopoulos, T
    LEUKEMIA & LYMPHOMA, 2002, 43 (01) : 111 - 114
  • [3] Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Santini, G
    Nati, S
    Spriano, M
    Gallamini, A
    Pierluigi, D
    Congiu, AM
    Truini, M
    Rubagotti, A
    Chisesi, T
    Vimercati, R
    Rossi, E
    Sertoli, MR
    Mattei, D
    Marino, G
    Gobbi, M
    HAEMATOLOGICA, 2001, 86 (03) : 282 - 286
  • [4] Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL)
    J. Braess
    K. Reich
    S. Willert
    F. Strutz
    C. Neumann
    W. Hiddemann
    B. Wörmann
    Annals of Hematology, 1997, 75 : 227 - 230
  • [5] Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL)
    Braess, J
    Reich, K
    Willert, S
    Strutz, F
    Neumann, C
    Hiddemann, W
    Wörmann, B
    ANNALS OF HEMATOLOGY, 1997, 75 (5-6) : 227 - 230
  • [6] Low-grade non-Hodgkin B-cell lymphoma presenting as sensory neuropathy
    Gemignani, F
    Marchesi, G
    DiGiovanni, G
    Salih, S
    Quaini, F
    NobileOrazio, E
    EUROPEAN NEUROLOGY, 1996, 36 (03) : 138 - 141
  • [7] Dosimetry results of Oncolym™ in the treatment of refractory B-cell non-Hodgkin's lymphoma (NHL).
    Verkh, LI
    Murray, JL
    Kripas, CJ
    Wessels, BW
    Varma, VM
    Kahn, D
    Bushnell, DL
    Serafini, AN
    Oliver, JC
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (01) : 66 - 66
  • [8] Hypocomplementemic urticaria with underlying low-grade non-Hodgkin's B-cell lymphoma
    Aldridge, C
    Choudhury, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P140 - P140
  • [9] Comparative economic analysis of the treatment of relapsed low grade B-cell non-Hodgkin's lymphoma (NHL) in France using chop, fludarabine or rituximab.
    Omnes, LF
    Foutel, V
    Haioun, C
    Jasso-Mosqueda, G
    Mathieu-Boue, A
    Hieke, K
    Kerrigan, M
    BLOOD, 1999, 94 (10) : 96A - 96A
  • [10] A Challenging Diagnosis: Low-Grade B-Cell Non-Hodgkin Lymphoma Coexisting With Follicular T-Cell Lymphoma
    Monge, Jose
    Rojas, Rafael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S504 - S504
12345